Drug developer BenevolentAI faces founder-led board revolt
BenevolentAI, a British-based drug developer, is facing a boardroom coup led by its founder after seeing its shares slump since it floated little more than two years ago.
Stay updated with breaking news from Inchcape. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BenevolentAI, a British-based drug developer, is facing a boardroom coup led by its founder after seeing its shares slump since it floated little more than two years ago.
Inchcape PLC's UK offering has attracted bid interest from New York-listed AutoNation Inc, Sky News reported on Monday. AutoNation is mulling a bid for the automotive distributor's UK operations. An...
Inchcape plc (OTCMKTS:IHCPF – Get Free Report) saw a large decline in short interest in March. As of March 15th, there was short interest totalling 108,000 shares, a decline of 6.0% from the February 29th total of 114,900 shares. Based on an average trading volume of 7,500 shares, the days-to-cover ratio is presently 14.4 days. […]
A takeover of Inchcape's UK dealerships would come months after AutoNation withdrew from a bidding war for rival British company Pendragon, Sky News learns.
Autonation is plotting a swoop for Inchcape UK, in what marks the latest sign of growing overseas interest in British car dealerships.